OpGen Receives FDA Clearance for Acuitas® AMR Gene Panel

OpGen’s Acuitas® AMR Gene Panel allows testing for a comprehensive panel of 28 genetic AMR markers in isolated bacterial colonies from 26 different pathogensAn aid to clinicians in the management

Related Keywords

United States ,Matthew Bretzius ,Oliver Schacht ,Johannes Bacher ,Curetis Gmb ,Jamesw Snyder ,Opgen Acuitas ,Centers For Disease ,Gene Panel For ,Opgen Press Contact ,Technology Platform ,Opgen Inc ,Drug Administration ,Nasdaq ,Exchange Commission ,Joe Green Edison Group ,Laboratory Medicine ,Securities Exchange ,Gene Panel ,University Of Louisville Hospital ,Molecular Diagnostics ,Louisville Hospital ,Disease Control ,Chief Operating Officer ,Curetis Gmbh ,Ares Genetics Gmbh ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Oliver Schacht President ,Gen Press Contact ,Fischtank Marketing ,Gen Investor Contact ,Money ,Ational ,